Compositions and methods for treating microbiota-associated psychiatric conditions and diseases

A technology of microorganisms and flora, applied in the direction of drug combination, neurological diseases, diseases resistant to vector transmission, etc., can solve problems such as irrationality and pain
CN105307654BActive Publication Date: 2022-06-07托马斯·朱利叶斯·波洛迪

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
托马斯·朱利叶斯·波洛迪
Publication Date
2022-06-07
Patent Text Reader

Abstract

In alternative embodiments, the present invention provides compositions and methods for the treatment, amelioration and prevention of various disorders and conditions in mammals, including genetically predisposed disorders and chronic disorders in which intestinal Microorganisms or bacterial flora in at least one etiological or symptom-producing factor, for example, where microorganisms or bacterial flora in the intestine produce neurotoxins or neurotoxic agents that enter through the gastrointestinal (GI) tract (e.g., the colon) body, and to systemic spaces, such as through neural streams or via circulation to the central nervous system (CNS), peripheral nervous system (PNS), and other nervous systems including the brain. In alternative embodiments, the methods and compositions of the invention comprise or involve the use of medicaments, formulations and medicaments comprising rifaximin or equivalent active agents which inhibit or Eradication of microbiota superinfections causing various psychiatric disorders. These compositions have been found to be effective in a wide range of disorders, particularly in the obsessive-compulsive disorder group (OCD).
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention generally relates to medicine, gastroenterology, pharmacology, and microbiology. In alternative embodiments, the present invention provides compositions and methods for treating, ameliorating, and preventing various disorders and conditions in mammals, including genetically predisposed disorders and chronic disorders, wherein intestinal The microorganisms or bacterial flora in the gut are at least one causative or symptom-producing factor, for example where the microorganisms or bacterial flora in the gut produce neurotoxins or neurotoxic agents, which enter the body through the gastrointestinal (GI) tract (e.g., the colon) and Access to systemic spaces, eg, via neural streams or via circulation to the central nervous system (CNS), peripheral nervous system (PNS), and other nervous systems including the brain. In alternative embodiments, the methods and compositions of the invention include or include the use of medicaments, formulations a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More